JP2016222537A - リン酸カルシウム焼結体粒子の製造方法 - Google Patents
リン酸カルシウム焼結体粒子の製造方法 Download PDFInfo
- Publication number
- JP2016222537A JP2016222537A JP2016137525A JP2016137525A JP2016222537A JP 2016222537 A JP2016222537 A JP 2016222537A JP 2016137525 A JP2016137525 A JP 2016137525A JP 2016137525 A JP2016137525 A JP 2016137525A JP 2016222537 A JP2016222537 A JP 2016222537A
- Authority
- JP
- Japan
- Prior art keywords
- ceramic
- particles
- particle
- particle group
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002245 particle Substances 0.000 title claims abstract description 265
- 239000001506 calcium phosphate Substances 0.000 title claims abstract description 59
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 title claims abstract description 59
- 229910000389 calcium phosphate Inorganic materials 0.000 title claims abstract description 58
- 235000011010 calcium phosphates Nutrition 0.000 title claims abstract description 58
- 238000004519 manufacturing process Methods 0.000 title claims description 29
- 239000000919 ceramic Substances 0.000 claims abstract description 135
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims abstract description 46
- 229910000019 calcium carbonate Inorganic materials 0.000 claims abstract description 23
- 239000011164 primary particle Substances 0.000 claims description 66
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 claims description 62
- 229910052588 hydroxylapatite Inorganic materials 0.000 claims description 61
- 238000000034 method Methods 0.000 claims description 40
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 32
- 239000013078 crystal Substances 0.000 claims description 30
- 230000008569 process Effects 0.000 claims description 21
- 238000005245 sintering Methods 0.000 claims description 18
- 239000012567 medical material Substances 0.000 claims description 12
- 239000002994 raw material Substances 0.000 claims description 11
- 238000010304 firing Methods 0.000 claims description 10
- 239000012736 aqueous medium Substances 0.000 claims description 9
- 239000000463 material Substances 0.000 claims description 9
- 230000008014 freezing Effects 0.000 claims description 8
- 238000007710 freezing Methods 0.000 claims description 8
- 230000003993 interaction Effects 0.000 claims description 8
- 230000008859 change Effects 0.000 claims description 7
- 238000010257 thawing Methods 0.000 claims description 6
- 238000004140 cleaning Methods 0.000 claims description 5
- 239000011575 calcium Substances 0.000 abstract description 9
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract description 5
- 229910052791 calcium Inorganic materials 0.000 abstract description 5
- 229960001714 calcium phosphate Drugs 0.000 description 46
- 238000005406 washing Methods 0.000 description 18
- 238000010298 pulverizing process Methods 0.000 description 11
- 239000002158 endotoxin Substances 0.000 description 10
- 230000000052 comparative effect Effects 0.000 description 9
- 239000008367 deionised water Substances 0.000 description 8
- 229910021641 deionized water Inorganic materials 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical group OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 7
- 238000009826 distribution Methods 0.000 description 7
- 239000002244 precipitate Substances 0.000 description 7
- 239000012620 biological material Substances 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 229920000642 polymer Polymers 0.000 description 6
- 238000002441 X-ray diffraction Methods 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- 239000003708 ampul Substances 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 229960005069 calcium Drugs 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 230000004927 fusion Effects 0.000 description 4
- 239000011163 secondary particle Substances 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- ZHJGWYRLJUCMRT-UHFFFAOYSA-N 5-[6-[(4-methylpiperazin-1-yl)methyl]benzimidazol-1-yl]-3-[1-[2-(trifluoromethyl)phenyl]ethoxy]thiophene-2-carboxamide Chemical compound C=1C=CC=C(C(F)(F)F)C=1C(C)OC(=C(S1)C(N)=O)C=C1N(C1=C2)C=NC1=CC=C2CN1CCN(C)CC1 ZHJGWYRLJUCMRT-UHFFFAOYSA-N 0.000 description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000011013 endotoxin removal Methods 0.000 description 3
- 239000010419 fine particle Substances 0.000 description 3
- 238000005187 foaming Methods 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 229920000307 polymer substrate Polymers 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000001179 sorption measurement Methods 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 229920002845 Poly(methacrylic acid) Polymers 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- MNNHAPBLZZVQHP-UHFFFAOYSA-N diammonium hydrogen phosphate Chemical compound [NH4+].[NH4+].OP([O-])([O-])=O MNNHAPBLZZVQHP-UHFFFAOYSA-N 0.000 description 2
- 229910000388 diammonium phosphate Inorganic materials 0.000 description 2
- 235000019838 diammonium phosphate Nutrition 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 239000002105 nanoparticle Substances 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 239000002861 polymer material Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- 239000002351 wastewater Substances 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 229910014497 Ca10(PO4)6(OH)2 Inorganic materials 0.000 description 1
- 229910021532 Calcite Inorganic materials 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 108010020346 Polyglutamic Acid Proteins 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 238000005411 Van der Waals force Methods 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- ROPDWRCJTIRLTR-UHFFFAOYSA-L calcium metaphosphate Chemical compound [Ca+2].[O-]P(=O)=O.[O-]P(=O)=O ROPDWRCJTIRLTR-UHFFFAOYSA-L 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 239000005548 dental material Substances 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000002296 dynamic light scattering Methods 0.000 description 1
- 230000009881 electrostatic interaction Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- -1 for example Substances 0.000 description 1
- 238000010559 graft polymerization reaction Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000001027 hydrothermal synthesis Methods 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- ABLZXFCXXLZCGV-UHFFFAOYSA-N phosphonic acid group Chemical group P(O)(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920002643 polyglutamic acid Polymers 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 238000000634 powder X-ray diffraction Methods 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000013094 purity test Methods 0.000 description 1
- 239000002510 pyrogen Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 239000004945 silicone rubber Substances 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L sulfate group Chemical group S(=O)(=O)([O-])[O-] QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 125000000542 sulfonic acid group Chemical group 0.000 description 1
- 238000013269 sustained drug release Methods 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 1
- 235000019731 tricalcium phosphate Nutrition 0.000 description 1
- 229940078499 tricalcium phosphate Drugs 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- NLVXSWCKKBEXTG-UHFFFAOYSA-N vinylsulfonic acid Chemical compound OS(=O)(=O)C=C NLVXSWCKKBEXTG-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Materials For Medical Uses (AREA)
- Dental Preparations (AREA)
- Compositions Of Oxide Ceramics (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2016137525A JP2016222537A (ja) | 2016-07-12 | 2016-07-12 | リン酸カルシウム焼結体粒子の製造方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2016137525A JP2016222537A (ja) | 2016-07-12 | 2016-07-12 | リン酸カルシウム焼結体粒子の製造方法 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2015073467A Division JP5980982B1 (ja) | 2015-03-31 | 2015-03-31 | リン酸カルシウム焼結体粒子の製造方法 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2019227088A Division JP2020063188A (ja) | 2019-12-17 | 2019-12-17 | リン酸カルシウム焼結体粒子の製造方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2016222537A true JP2016222537A (ja) | 2016-12-28 |
JP2016222537A5 JP2016222537A5 (enrdf_load_stackoverflow) | 2018-05-17 |
Family
ID=57745469
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2016137525A Pending JP2016222537A (ja) | 2016-07-12 | 2016-07-12 | リン酸カルシウム焼結体粒子の製造方法 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2016222537A (enrdf_load_stackoverflow) |
-
2016
- 2016-07-12 JP JP2016137525A patent/JP2016222537A/ja active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5980982B1 (ja) | リン酸カルシウム焼結体粒子の製造方法 | |
KR100898218B1 (ko) | 세라믹입자군 및 그 제조방법 그리고 그 이용 | |
JP6072968B1 (ja) | リン酸カルシウム焼結体粒子の製造方法 | |
JP6072967B1 (ja) | リン酸カルシウム焼結体粒子の製造方法 | |
CN109415210B (zh) | 磷酸钙烧结体粒子及其制造方法 | |
Pramanik et al. | Capping agent-assisted synthesis of nanosized hydroxyapatite: comparative studies of their physicochemical properties | |
Baskaran et al. | Synthesis methods of doped hydroxyapatite: a brief review | |
Gandou et al. | Nanosized calcium-deficient carbonated hydroxyapatite synthesized by microwave activation | |
JP6548616B2 (ja) | 医療用インプラント | |
JP7125754B2 (ja) | リン酸カルシウム焼結体粒子及びその製造方法 | |
JP2021181400A (ja) | リン酸カルシウム焼結体粒子の製造方法 | |
JP2016222537A (ja) | リン酸カルシウム焼結体粒子の製造方法 | |
JP2018002580A (ja) | リン酸カルシウム焼結体粒子の製造方法 | |
JP7125755B2 (ja) | 新規なセラミック粒子複合材料 | |
JP6548617B2 (ja) | コラーゲン産生促進剤 | |
JP6555722B2 (ja) | 歯面修復材 | |
Kumar et al. | Growth and characterization of nano‐crystalline hydroxyapatite at physiological conditions | |
JP6548618B2 (ja) | セラミック粒子担持医療用シート | |
Madrigal et al. | Comparison of the physicochemical properties and osteoblast viability of nanocrystalline hydroxyapatite synthesized in batch and continuous systems | |
WO2018043623A1 (ja) | セラミック粒子担持ステント | |
JP2018002579A (ja) | リン酸カルシウム焼結体粒子の製造方法 | |
CN110615417A (zh) | 多孔结构磷酸钙有机-无机复合材料及其制备方法 | |
WO2018043620A1 (ja) | セラミック粒子担持医療用チューブ及び/又はカフ | |
Jose et al. | A Review on Nano Hydroxyapatite Fabrication Techniques | |
Klinkaewnarong et al. | Synthesis of nanocrystalline hydroxyapatite by natural biopolymers based Sol-Gel technique |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20180326 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20180326 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20190319 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20190917 |